Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 26, Number 11—November 2020
Synopsis

Challenges to Achieving Measles Elimination, Georgia, 2013–2018

Nino KhetsurianiComments to Author , Ketevan Sanadze, Rusudan Chlikadze, Nazibrola Chitadze, Tamar Dolakidze, Tamta Komakhidze, Lia Jabidze, Shahin Huseynov, Myriam Ben Mamou, Claude Muller, Khatuna Zakhashvili, and Judith M. Hübschen
Author affiliations: Centers for Disease Control and Prevention, Atlanta, Georgia, USA (N. Khetsuriani); CDC South Caucasus Office, Tbilisi, Georgia (N. Khetsuriani); National Center for Disease Control and Public Health, Tbilisi (K. Sanadze, R. Chlikadze, N. Chitadze, T. Dolakidze, T. Komakhidze, L. Jabidze, K. Zakhashvili); South Caucasus Field Epidemiology and Laboratory Training Program, Tbilisi (T. Komakhidze); World Health Organization European Regional Office, Copenhagen, Denmark (S. Huseynov, M. Ben Mamou); World Health Organization European Regional Reference Laboratory for Measles and Rubella, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg (C. Muller, J.M. Hübschen)

Main Article

Table 1

Epidemiologic characteristics of reported measles case-patients, Georgia, 2013–2018*

Characteristic Reported measles cases, no. (%)
2013–2015 outbreak 2016 2017–2018 outbreak
Total cases
11,495 (100.0)
14 (100.0)
2,295 (100.0)
Final case classification category
Laboratory-confirmed 1220 (10.6) 5 (35.7) 1,748 (76.1)
Epidemiologically linked 466 (4.1) 0 (0) 112 (4.9)
Clinically compatible
9,809 (85.3)
9 (64.3)
435 (19.0)
Sex
M 6,000 (52.4) 8 (57.1) 1133 (49.4)
F
5,457 (47.6)
6 (42.9)
1162 (50.6)
Age group, y
<1 1,130 (9.8) 4 (28.7) 229 (10.0)
1–4 1,707 (14.9) 6 (42.9) 321 (14.0)
5–9 962 (8.4) 0 (0) 167 (7.3)
10–14 751 (6.5) 1 (7.1) 174 (7.6)
15–19 1,286 (11.2) 0 (0) 164 (7.1)
20–24 1,707 (14.8) 1 (7.1) 302 (13.2)
25–29 1,750 (15.2) 1 (7.1) 304 (13.2)
30–39 1,546 (13.5) 0 (0) 441 (19.2)
40–49 477 (4.1) 0 (0) 143 (6.2)
>50
179 (1.6)
1 (7.1)
50 (2.2)
No. of doses of measles-containing vaccine received
0 3,972 (34.6) 7 (50.0) 981 (42.7)
>1 1,346 (11.7) 4 (28.7) 183 (8.0)
1 1,020 (8.9) 4 (28.7) 123 (5.4)
2 326 (2.8) 0 (0) 60 (2.6)
Unknown
6,177 (53.7)
3 (21.3)
1131 (49.3)
Region
Tbilisi 5,364 (47.0) 7 (50.0) 864 (37.6)
Achara 270 (2.4) 4 (28.7) 380 (16.6)
Guria 87 (0.8) 0 (0) 50 (2.2)
Imereti 742 (6.5) 0 (0) 469 (20.4)
Kakheti 610 (5.3) 1 (7.1) 36 (1.6)
Kvemo Kartli 1,159 (10.2) 0 (0) 87 (3.8)
Mtskheta-Mtianeti 286 (2.5) 1 (7.1) 29 (1.2)
Racha-Lechkhumi-Kvemo Svaneti 83 (0.7) 0 (0) 13 (0.6)
Samegrelo-Zemo-Svaneti 1,200 (10.5) 1 (7.1) 289 (12.6)
Samtskhe-Javakheti 83 (0.7) 0 (0) 28 (1.2)
Shida Kartli 1,509 (13.2) 0 (0) 36 (1.6)
Abkhazia 27 (0.2) 0 (0) 14 (0.6)

*Sex was not reported for 34 cases during 2013–2015. Region was not specified for 75 cases during 2013–2015. For Abkhazia, currently outside Georgia Government control, only cases treated in healthcare facilities in the government-controlled areas are reported.

Main Article

Page created: September 14, 2020
Page updated: October 17, 2020 10:15 PM EDT
Page reviewed: October 17, 2020 10:15 PM EDT
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external